How the Uptick in Opioid Litigation is Affecting the Industry: Key Takeaways from the MDLs
2nd Annual Summit on Controlled Substances – Regulation, Litigation, and Enforcement
In the year that has passed since the inaugural event, the Judicial Panel on Multidistrict Litigation has centralized more than 1100 opioid-related lawsuits in the Northern District of Ohio- National Prescription Opiate Litigation, MDL #2804. The DOJ has joined the case as a “friend of the court” to assist with settlement negotiations. Presently, the MDL trial is set for September 2019, with ongoing potential settlement discussions.
In this session, Ed Rickert and his co-presenter will take a deep dive into the MDL as well as similar proceedings such as the Native American Tribe suits and the Texas counties MDL. Speakers will provide a thorough analysis of how the outcomes of these cases will affect your business and manufacturing practices.
Topics of discussion include:
- Dissecting the strength of proposed arguments and defenses
- Understanding the unique challenges of each of these proceedings
- Evaluating strategies and potential outcomes
More information on the conference can be found here: https://www.americanconference.com/controlled-substances-summit/